Multiple myeloma — VA Rating Criteria (38 CFR DC 7712)

The VA rates Multiple myeloma under Diagnostic Code 7712 at the following tiers: 0%, 100%. The minimum 0% rating requires: Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS). The maximum 100% rating requires: Symptomatic multiple myeloma.

Diagnostic Code 7712 is the VA rating identifier for Multiple myeloma within 38 CFR 38 CFR § 4.117. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

The highest schedular rating for Multiple myeloma under DC 7712 is 100%. This tier requires: Symptomatic multiple myeloma. Veterans who cannot secure substantially gainful employment due to Multiple myeloma alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.

Multiple myeloma is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7712. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Secondary conditions caused or aggravated by Multiple myeloma may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.

Service connection for Multiple myeloma requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.